Introduction

EmtelliPro+, a product of emtelligent, is an advanced medical AI platform that uses a novel, medically aligned deep-learning approach for Large Language Models (LLMs) to provide actionable insights and auditable answers for today’s healthcare teams.

About Emtelligent

Emtelligent, a leader in the development of clinical-grade Natural Language Processing (NLP) software, has developed the most accurate and feature-rich medical AI platform on the market. Based in Vancouver, British Columbia, emtelligent has combined NLP and LLMs, rigorously trained on vast amounts of annotated medical data, to drive actionable insights.

The Need for EmtelliPro+

Healthcare organizations are overwhelmed by terabytes of clinical data, 80% of which is unstructured. This data is in a variety of formats, across multiple silos and business units. EmtelliPro+ helps healthcare organizations get the most out of their data and provides the full health picture for patients, plan members, and population cohorts.

Benefits of EmtelliPro+

For Healthcare Organizations

• Accuracy and Safety: EmtelliPro+ represents the next generation of medical AI, providing healthcare professionals with the tool they need to quickly and easily access relevant patient data and make safe and accurate determinations.
• User-Friendly Interface: With a simple and intuitive interface, clinical and business users can quickly get answers and insights about patients and population cohorts.
• Data Utilization: EmtelliPro+ helps healthcare organizations get the most out of their data and provides the full health picture for patients, plan members, and population cohorts.

For Health Insurance Carriers

• Risk Assessment: The platform can deliver health insurance carriers an unprecedented look at the health and risk of their members, previously only accessible through manual chart review.
• Underwriting Accuracy: EmtelliPro+ also improves underwriting accuracy, enables Medicare and ACA risk adjustment performance, speeds or automates prior authorization approvals, and much more through an AI-assisted, conversational interface.

For Pharmaceutical Companies and Clinical Research Organizations (CROs)

• Clinical Trials: EmtelliPro+ unlocks the ability to accrue patients to clinical trials. Using EmtelliPro+, researchers can quickly process millions of patients for inclusion and/or exclusion criteria to seat their panel, monitor real-world evidence, and evaluate therapeutic efficacy.

For Health Systems and EHR Platforms

• Quality Performance and Workforce Productivity: Health systems and EHR platforms can leverage EmtelliPro+ to improve quality performance and workforce productivity. The platform instantly and accurately summarizes patient medical histories, speeding care transitions and identifying important gaps in care and coding improvement opportunities.

Conclusion

Unlock the power of the full patient record now with EmtelliPro+ and improve care outcomes, reduce costs, drive revenue, and fuel research breakthroughs. Emtelligent will be demonstrating the new EmtelliPro+ platform at HIMSS24, Booth 3185. Learn more or schedule a demo at emtelligent.com.

References

: Source: Original Article